SCHEMBL5103473

SCHEMBL5103473

CCOC(=O)c1nn(S(=O)(=O)c2ccccc2)c2cc(N3CCN(C)CC3)ccc12

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.48
DRD2 P14416 3/20 0.48
HTR1A P08908 1/20 0.48
KHK P50053 2/20 0.45
DRD3 P35462 2/20 0.44
RXFP1 Q9HBX9 1/20 0.44
CYP2C9 P11712 1/20 0.43
ELANE P08246 2/20 0.43
THRB P10828 1/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MCOLN3 Q8TDD5 1/20 0.42
HTR2C P28335 1/20 0.42
HTR7 P34969 1/20 0.42
HTR2B P41595 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5095089 0.90 HTR6 (0.48) HTR6KHKDRD3ELANEALDH1A1
SCHEMBL5103496 0.87 HTR6 (0.54) HTR6DRD2HTR1AKHKDRD3
SCHEMBL5103467 0.86 HSD11B1 (0.39) KHKRXFP1CYP2C9ELANETHRB
SCHEMBL5097497 0.84 THRB (0.40) HTR6DRD2HTR1AKHKRXFP1
SCHEMBL5097131 0.82 USP9X (0.40) RXFP1CYP2C9ELANEALDH1A1HTT
SCHEMBL5091069 0.81 KHK (0.65) HTR6DRD2HTR1AKHKDRD3
SCHEMBL5097527 0.81 HTR6 (0.41) HTR6KHKELANEALDH1A1HTT
SCHEMBL14140342 0.77 HTR6 (0.54) HTR6DRD2HTR1AKHKDRD3
SCHEMBL5095012 0.76 THRB (0.38) HTR6DRD2HTR1AKHKTHRB
SCHEMBL5097139 0.74 GHSR (0.39) HTR6ELANEALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US claimed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
WO-2008101247-A2 6 ' SUBSTITUTED INDOLE AND INDAZOLE DERIVATIVES HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR1B, HTR1A HTR6 1/4885DRD2 19/4885HTR1A 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.